SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,726 | -43.5% | 166,265 | +22.5% | 0.03% | -44.0% |
| Q2 2023 | $176,495 | -26.1% | 135,765 | 0.0% | 0.05% | -61.2% |
| Q1 2023 | $238,946 | -73.4% | 135,765 | -12.0% | 0.13% | -71.4% |
| Q1 2022 | $897,000 | -16.8% | 154,360 | +7.4% | 0.45% | -17.2% |
| Q4 2021 | $1,078,000 | -6.2% | 143,768 | +12.7% | 0.54% | +16.5% |
| Q3 2021 | $1,149,000 | -24.6% | 127,565 | +0.2% | 0.47% | -20.4% |
| Q2 2021 | $1,524,000 | -3.9% | 127,308 | +0.6% | 0.59% | -35.0% |
| Q1 2021 | $1,586,000 | -17.9% | 126,608 | +2.3% | 0.90% | -32.0% |
| Q4 2020 | $1,932,000 | – | 123,817 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |